339 related articles for article (PubMed ID: 38539233)
1. From gene to mechanics: a comprehensive insight into the mechanobiology of LMNA mutations in cardiomyopathy.
Veltrop RJA; Kukk MM; Topouzidou K; Didden L; Muchir A; van Steenbeek FG; Schurgers LJ; Harakalova M
Cell Commun Signal; 2024 Mar; 22(1):197. PubMed ID: 38539233
[TBL] [Abstract][Full Text] [Related]
2. Current insights into LMNA cardiomyopathies: Existing models and missing LINCs.
Brayson D; Shanahan CM
Nucleus; 2017 Jan; 8(1):17-33. PubMed ID: 28125396
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of fibroblasts in a family with LMNA-related cardiomyopathy reveals molecular pathways implicated in disease pathogenesis.
Widyastuti HP; Norden-Krichmar TM; Grosberg A; Zaragoza MV
BMC Med Genet; 2020 Jul; 21(1):152. PubMed ID: 32698886
[TBL] [Abstract][Full Text] [Related]
4. Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation.
Choi JC; Wu W; Muchir A; Iwata S; Homma S; Worman HJ
J Biol Chem; 2012 Nov; 287(48):40513-24. PubMed ID: 23048029
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cytoskeleton in cardiomyopathy caused by mutations in
Chatzifrangkeskou M; Le Dour C; Muchir A
Am J Physiol Cell Physiol; 2023 Jun; 324(6):C1223-C1235. PubMed ID: 37125775
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins.
Muchir A; Shan J; Bonne G; Lehnart SE; Worman HJ
Hum Mol Genet; 2009 Jan; 18(2):241-7. PubMed ID: 18927124
[TBL] [Abstract][Full Text] [Related]
7. Skeletal and Cardiac Muscle Disorders Caused by Mutations in Genes Encoding Intermediate Filament Proteins.
Maggi L; Mavroidis M; Psarras S; Capetanaki Y; Lattanzi G
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923914
[TBL] [Abstract][Full Text] [Related]
8. Microtubule cytoskeleton regulates Connexin 43 localization and cardiac conduction in cardiomyopathy caused by mutation in A-type lamins gene.
Macquart C; Jüttner R; Morales Rodriguez B; Le Dour C; Lefebvre F; Chatzifrangkeskou M; Schmitt A; Gotthardt M; Bonne G; Muchir A
Hum Mol Genet; 2019 Dec; 28(24):4043-4052. PubMed ID: 29893868
[TBL] [Abstract][Full Text] [Related]
9. Elevated dual specificity protein phosphatase 4 in cardiomyopathy caused by lamin A/C gene mutation is primarily ERK1/2-dependent and its depletion improves cardiac function and survival.
Choi JC; Wu W; Phillips E; Plevin R; Sera F; Homma S; Worman HJ
Hum Mol Genet; 2018 Jul; 27(13):2290-2305. PubMed ID: 29668927
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics in
Wang Y; Dobreva G
Cells; 2023 Mar; 12(5):. PubMed ID: 36899919
[TBL] [Abstract][Full Text] [Related]
11. Cell signaling abnormalities in cardiomyopathy caused by lamin A/C gene mutations.
Worman HJ
Biochem Soc Trans; 2018 Feb; 46(1):37-42. PubMed ID: 29196611
[TBL] [Abstract][Full Text] [Related]
12. Deciphering Nuclear Mechanobiology in Laminopathy.
Hah J; Kim DH
Cells; 2019 Mar; 8(3):. PubMed ID: 30862117
[TBL] [Abstract][Full Text] [Related]
13. Lamin A/C Mechanotransduction in Laminopathies.
Donnaloja F; Carnevali F; Jacchetti E; Raimondi MT
Cells; 2020 May; 9(5):. PubMed ID: 32456328
[TBL] [Abstract][Full Text] [Related]
14. Functional Characterization of a Novel Truncating Mutation in Lamin A/C Gene in a Family with a Severe Cardiomyopathy with Conduction Defects.
Gerbino A; Bottillo I; Milano S; Lipari M; Zio R; Morlino S; Mola MG; Procino G; Re F; Zachara E; Grammatico P; Svelto M; Carmosino M
Cell Physiol Biochem; 2017; 44(4):1559-1577. PubMed ID: 29197877
[TBL] [Abstract][Full Text] [Related]
15. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
16. Attenuated hypertrophic response to pressure overload in a lamin A/C haploinsufficiency mouse.
Cupesi M; Yoshioka J; Gannon J; Kudinova A; Stewart CL; Lammerding J
J Mol Cell Cardiol; 2010 Jun; 48(6):1290-7. PubMed ID: 19913544
[TBL] [Abstract][Full Text] [Related]
17. Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity.
Tan CY; Chan PS; Tan H; Tan SW; Lee CJM; Wang JW; Ye S; Werner H; Loh YJ; Lee YL; Ackers-Johnson M; Foo RSY; Jiang J
J Transl Med; 2023 Oct; 21(1):690. PubMed ID: 37840136
[TBL] [Abstract][Full Text] [Related]
18. The structure and function of lamin A/C: Special focus on cardiomyopathy and therapeutic interventions.
Tiwari V; Alam MJ; Bhatia M; Navya M; Banerjee SK
Life Sci; 2024 Mar; 341():122489. PubMed ID: 38340979
[TBL] [Abstract][Full Text] [Related]
19. Perinuclear damage from nuclear envelope deterioration elicits stress responses that contribute to
Sikder K; Phillips E; Zhong Z; Wang N; Saunders J; Mothy D; Kossenkov A; Schneider T; Nichtova Z; Csordas G; Margulies KB; Choi JC
Sci Adv; 2024 May; 10(19):eadh0798. PubMed ID: 38718107
[TBL] [Abstract][Full Text] [Related]
20. Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation.
Choi JC; Muchir A; Wu W; Iwata S; Homma S; Morrow JP; Worman HJ
Sci Transl Med; 2012 Jul; 4(144):144ra102. PubMed ID: 22837537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
